Behavioral functioning and treatment adherence in pediatric inflammatory bowel disease: Review and recommendations for practice

Gastroenterology and Hepatology

Volumn 4, Issue 11, 2008, Pages 785-791

  Hommel, Kevin A ^a,b   Denson, Lee A ^a,b   Crandall, Wallace V ^c,d   Mackner, Laura M ^c,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adherence; Compliance; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; TIOGUANINE;

BEHAVIOR DISORDER; DOCTOR PATIENT RELATION; ENTERITIS; HUMAN; PATIENT COMPLIANCE; REVIEW; RISK FACTOR;

EID: 57749195918     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
2. Mackner LM, Crandall WV. Brief report: psychosocial adjustment in adolescents with inflammatory bowel disease. J Pediatr Psychol. 2006;31:281-285.
3. Drossman DA, Ringel Y. Psychosocial factors in ulcerative colitis and Crohn's disease. In: Sartor RB, Sandborn W, eds. Kirsner's Inflammatory Bowel Disease. 6th ed. Philadelphia, Pa: Saunders; 2003:340-356.
4. Mackner LM, Sisson DP, Crandall WV. Review: psychosocial issues in pediatric inflammatory bowel disease. J Pediatr Psychol. 2004;29:243-257.
5. Hommel KA, Mackner LM, Denson LA, Crandall WV. Treatment regimen adherence in pediatric gastroenterology. J Pediatr Gastroenterol Nutr. In press.
6. Mackner LM, Crandall WV, Szigethy EM. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:239-244.
7. Mackner LM, Crandall WV. Psychological factors affecting pediatric inflammatory bowel disease. Curr Opin Pediatr. 2007;19:548-552.
8. Burke P, Meyer V, Kocoshis S, Orenstein DM, Chandra R, et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry. 1989;28:948-951.
9. Burke P, Neigut D, Kocoshis S, Chandra R, Sauer J. Correlates of depression in new onset pediatric inflammatory bowel disease. Child Psychiatry Hum Dev. 1994;25:275-283.
10. Engstrom I. Parental distress and social interaction in families with children with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 1991;30:904-912.
11. Engstrom I. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J Child Psychol Psychiatry. 1992;33:563-582.
12. Engstrom I. Inflammatory bowel disease in children and adolescents: mental health and family functioning. J Pediatr Gastroenterol Nutr. 1999;28:S28-S33.
13. Engstrom I, Lindquist BL. Inflammatory bowel disease in children and adolescents: a somatic and psychiatric investigation. Acta Paediatr. 1991;80:640-647.
14. Wood B, Watkins JB, Boyle JT, Nogueria J, Zimand E, Carroll L. Psychological functioning in children with Crohn's disease and ulcerative colitis: implications for models of psychobiological interaction. J Am Acad Child Adolesc Psychiatry. 1987;26:774-781.
15. Mackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. Am J Gastroenterol. 2005;100:1386-1392.
16. Wood B, Watkins JB, Boyle JT, Nogueria J, Zimand E, Carroll L. The "psychosomatic family" model: an empirical and theoretical analysis. Family Process. 1989;28:399-417.
17. Burke P, Kocoshis SA, Chandra R, Whiteway M, Sauer J. Determinants of depression in recent onset pediatric inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 1990;29:608-610.
18. Tojek TM, Lumley MA, Corlis M, Ondersma S, Tolia V. Maternal correlates of health status in adolescents with inflammatory bowel disease. J Psychosom Res. 2002;52:173-179.
19. Burke P, Kocoshis S, Neigut D, Sauer J, Chandra R, Orenstein D. Maternal psychiatric disorders in pediatric inflammatory bowel disease and cystic fibrosis. Child Psychiatry Hum Dev. 1994;25:45-52.
20. Wood B, Boyle JT, Watkins JB, Nogueria J, Zimand E, Carroll L. Sibling psychological status and style as related to the disease of their chronically ill brothers and sisters: implications for models of biopsychosocial interaction. J Dev Behav Pediatr. 1988;9:66-72.
21. Burke P, Meyer V, Kocoshis S, Orenstein DM, Chandra R, Sauer J. Obsessive-compulsive symptoms in childhood inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry. 1989;28:525-527.
22. Ondersma SJ, Lumley MA, Corlis ME, Tojek TM, Tolia V. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health. J Pediatr Psychol. 1997;22:723-738.
23. Steinhausen HC, Kies H. Comparative studies of ulcerative colitis and Crohn's disease in children and adolescents. J Child Psychol Psychiatry. 1982;23:33-42.
24. Loonen HJ, Grootenhuis MA, Last BF, de Haan RJ, Bouquet J, Derkx BH. Measuring quality of life in children with inflammatory bowel disease: the Impact-II (NL). Qual Life Res. 2002;11:47-56.
25. Loonen HJ, Derkx BHF, Koopman HM, Heymans HS. Are parents able to rate the symptoms and quality of life of their offspring with IBD? Inflamm Bowel Dis. 2002;8:270-276.
26. Otley A, Smith C, Nicholas D, Munk M, Avolio J, et al. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;35:557-563.
27. Griffiths AM, Nicholas D, Smith C, Munk M, Stephens D, et al. Development of a quality of life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr. 1999;28:S46-S52.
28. MacPhee M, Hoffenberg EJ, Feranchak A. Quality of life factors in adolescent inflammatory bowel disease. Inflamm Bowel Dis. 1998;4:6-11.
29. Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, et al. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:684-691.
30. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006;12:697-707.
31. Mikocka-Walus AA, Tumbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis. 2007;13:225-234.
32. Riekert KA, Drotar D. The beliefs about medication scale: development, reliability, and validity. J Clin Psychol Med Settings. 2002;9:177-184.
33. Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:1006-1012.
34. Oliva-Hemker MM, Abadom V, Cuffari C, Thompson RE. Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn's disease. J Pediatr Gastroenterol Nutr. 2007;44:180-184.
35. Hommel KA, Davis CM, Baldassano RN. Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol. 2008;33:867-874.
36. Kovacs M, Goldston D, Obrosky DS, Iyengar S. Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry. 1992;31:1112-1119.
37. La Greca AM, Follansbee D, Skyler JS. Developmental and behavioral aspects of diabetes management in youngsters. Children Health Care. 1990;19:132-137.
38. Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol. 1990;15:477-492.
39. Jacobson AM, Hauser ST, Lavori P, Wolfsdorf JI, Herskowitz RD, et al. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: I. The influence of patient coping and adjustment. J Pediatr Psychol. 1990;15:511-526.
40. Christophersen ER. Pediatric Compliance: A Guide for the Primary Care Physician. New York, NY: Plenum; 1994.
41. Brownbridge G, Fielding DM. Psychosocial adjustment and adherence to dialysis treatment regimens. Pediatr Nephrol. 1994;8:744-749.
42. Shaw RJ, Palmer L, Blasey C, Sarwal M. A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant. 2003;7:489-493.
43. Gerson AC, Furth SL, Neu AM, Fivush BA. Assessing associations between medication adherence and potentially modifiable psychosocial variables in pediatric kidney transplant recipients and their families. Pediatr Transplant. 2004;8:543-550.
44. Smith BA, Schuchman M. Problem of nonadherence in chronically ill adolescents: strategies for assessment and intervention. Curr Opin Pediatr. 2005;17:613-618.
45. Rapoff MA. Adherence to Pediatric Medical Regimens. New York, NY: Kluwer Academic; 1999.
46. Ingersoll GM, Orr DP, Herrold AJ, Golden MP. Cognitive maturity and self-management among adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1986;108:620-623.
47. Shemesh E, Shneider BL, Savitzky JK, Arnott L, Gondolesi GE, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113:825-832.
48. McQuaid EL, Kopel SJ, Klein RB, Fritz GK. Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. J Pediatr Psychol. 2003;28:323-333.
49. Wynn KS, Eckel EM. Juvenile rheumatoid arthritis and home physical therapy program compliance. Phys Occup Ther Pediatr. 1986;6:55-63.
50. Hazzard A, Hutchinson SJ, Krawiecki N. Factors related to adherence to medication regimens in pediatric seizure patients. J Pediatr Psychol. 1990;15:543-555.
51. Chaney JM, Peterson L. Family variables and disease management in juvenile rheumatoid arthritis. J Pediatr Psychol. 1989;14:389-403.
52. Hauser ST, Jacobson AM, Lavori P, Wolfsdorf JI, Herskowitz RD, et al. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: II. Immediate and long-term linkages with the family milieu. J Pediatr Psychol. 1990;15:527-542.
53. Griffin KJ, Elkin DT. Nonadherence in pediatric transplantation: a review of the existing literature. Pediatr Transplant. 2001;5:246-249.
54. Lemanek KL, Kamps J, Chung NB. Empirically supported treatments in pediatric psychology: regimen adherence. J Pediatr Psychol. 2001;26:253-275.
55. DiMatteo MR. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Couns. 2004;55:339-344.
56. DeLambo KE, Ievers-Landis CE, Drotar D, Quittner AL. Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis. J Pediatr Psychol. 2004;29:343-353.
57. Wysocki T, Harris MA, Greco P, Bubb J, Danda CE, et al. Randomized, controlled trial of behavior therapy for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol. 2000;25:23-33.
58. Anderson BJ, Bracket J, Ho J, Laffel LMB. An intervention to promote family teamwork in diabetes management tasks: relationships among parental involvement, adherence to blood glucose monitoring, and glycemic control in young adolescents with type 1 diabetes. In: Drotar D, ed. Promoting Adherence to Medical Treatment in Chronic Childhood Illness. Mahwah, NJ: Lawrence Erlbaum Associates; 2000:347-365.
59. Satin W, La Greca AM, Zigo MA, Skyler JS. Diabetes in adolescence: effects of multifamily group intervention and parent simulation of diabetes. J Pediatr Psychol. 1989;14:259-275.
60. Mackner LM, McGrath AM, Stark LJ. Dietary recommendations to prevent and manage chronic pediatric health conditions: adherence, intervention, and future directions. J Dev Behav Pediatr. 2001;22:130-143.
61. Kyngas H, Rissanen M. Support as a crucial predictor of good compliance of adolescents with a chronic disease. J Clin Nurs. 2001;10:767-774.
62. Wysocki T, Gavin L. Paternal involvement in the management of pediatric chronic diseases: associations with adherence, quality of life, and health status. J Pediatr Psychol. 2006;31:501-511.